Acetaminophen (Neuro-developmental outcomes)

Table   Graphic  
individual studies
OutcomeTE95% CIn casesn exposedkPub. bias Neuro-developmental disorders ADHD (Attention deficit hyperactivity disorder): Diagnosis/Risk Liew, 2014 Ystrom or Gustavson (Ystrom - Population-Based), 2017 Tovo-Rodrigues, 2018 Chen, 2019 Sznajder, 2022 Ahlqvist (Population-Based), 2024 61.17[1.08; 1.27]149,447280,000serious ADHD (Attention deficit hyperactivity disorder): Diagnosis Liew, 2014 Ystrom or Gustavson (Ystrom - Population-Based), 2017 Chen, 2019 Ahlqvist (Population-Based), 2024 41.16[1.05; 1.29]148,170278,039not evaluable Language disorders/delay Liew a, 2016 Tronnes, 2020 Bertoldi_Pelotas, 2020 Tovo-Rodrigues, 2020 Woodbury a, 2024 51.00[0.99; 1.01]1,88611,739not evaluable ADHD (Attention deficit hyperactivity disorder): Risk Tovo-Rodrigues, 2018 Inoue, 2021 Sznajder, 2022 31.15[1.06; 1.24]3,06923,631not evaluable ASD (Autism spectrum disorder): Diagnosis Liew b, 2016 Ahlqvist (Population-Based), 2024 21.10[0.98; 1.24]69,611222,096not evaluable ASD (Autism spectrum disorder): Diagnosis/Risk Liew b, 2016 Ahlqvist (Population-Based), 2024 21.10[0.98; 1.24]69,611222,096not evaluable Psychomotor developmental disorders/delay Vlenterie, 2016 Tovo-Rodrigues, 2020 Bertoldi_Pelotas, 2020 30.99[0.89; 1.10]2,58615,973not evaluable Cognitive developmental disorders/delay (< 3 years old) Tovo-Rodrigues, 2020 Bertoldi_Pelotas, 2020 20.93[0.83; 1.03]-2,470not evaluable Cognitive developmental disorders/delay (> 6 years old) Ahlqvist (Population-Based), 2024 11.05[1.00; 1.10]24,554185,909not evaluable Severe cognitive developmental delay (Mental retardation) (> 6 years old) Ahlqvist (Population-Based), 2024 11.05[1.00; 1.10]24,554185,909not evaluable ASD (Autism spectrum disorder): Risk Alemany_DNBC, 2021 11.28[1.10; 1.49]72934,584not evaluable Childhood autism (F84.0) Liew b, 2016 11.10[0.89; 1.36]34536,187not evaluable Cognitive developmental disorders/delay (3-6 years old) Liew a, 2016 11.16[0.96; 1.40]-881not evaluable0.85.01.0